EZSolution™ CP-690550

A 10 mM (5 mg in 1.60 ml) solution of the potent JAK3 inhibitor CP-690550 (Cat. No. 1622) in anhydrous DMSO.

Alternate Name/Synonyms: EZSolution™ Tasocitinib; EZSolution™ Tofacitinib, (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile, 1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo [2,3-d]pyrimidin-4-yl-3-piperidinamine

Appearance: Liquid

Appearance: A 10 mM solution in anhydrous DMSO

Appearance: 477600-75-2

Appearance: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₆H₂₀N₆O

Molecular Weight: 312.37

Cell-Permeable?: True

Purity: ≥98% by HPLC

Solubilities:

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A potent JAK3 inhibitor

MDL Number:

PubChem CID: 9926791

SMILES: CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N

InChi: InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1

InChi Key: UJLAWZDWDVHWOW-YPMHNXCESA-N

Category: Biochemicals